Skip to main content
Top
Published in: Rheumatology International 9/2022

08-06-2022 | Joint Pain | Observational Research

Seasonal residual activity in adult familial Mediterranean fever: a longitudinal observational study

Authors: Sevtap Acer Kasman, Mehmet Tuncay Duruöz

Published in: Rheumatology International | Issue 9/2022

Login to get access

Abstract

Although it is assumed that cold exposure triggers inflammation in patients with familial Mediterranean fever (FMF), seasonal differences in FMF have not yet been investigated. This study aims to investigate the association of seasonal changes with the frequency of attacks, disease severity, and subclinical inflammation in FMF. This longitudinal study examined adult patients with FMF on an established treatment followed up for at least 1 year in Istanbul. Clinical characteristics, medications, intraseasonal attacks counts, arthralgia and arthritis, disease severity, and the subclinical inflammation parameters were recorded covering four seasons. Friedman’s and Cochran’s Q tests were used to analyze changes in the above-mentioned data over seasons. Additionally, all attacks experienced in each season were added, and interseasonal differences were compared with the Chi-square goodness-of-fit test. Data for 240 observations (60 patients) were analyzed. The mean age and disease duration were 39.78 (SD 11.91) and 10 (IQR 6–22.75) years, respectively. The comparison of medians for four seasons did not show any statistical differences in terms of attack frequency, disease severity parameters, markers of subclinical inflammation, and the presence of arthralgia and arthritis. The total number of intraseasonal attacks experienced by patients differed among the seasons (p = 0.023), with a higher count in winter. Adult individuals with established FMF are more likely to experience attacks in winter than summer, but this difference may not be seen in the general parameters of disease activity/severity. This result supports the notion that there is a pronounced residual activity in winter.
Literature
3.
go back to reference La Regina M, Ben-Chetrit E, Gasparyan AY et al (2013) Current trends in colchicine treatment in familial Mediterranean fever. Clin Exp Rheumatol 31:41–46PubMed La Regina M, Ben-Chetrit E, Gasparyan AY et al (2013) Current trends in colchicine treatment in familial Mediterranean fever. Clin Exp Rheumatol 31:41–46PubMed
9.
go back to reference Hawley DJ, Wolfe F, Lue FA, Moldofsky H (2001) Seasonal symptom severity in patients with rheumatic diseases: a study of 1424 patients. J Rheumatol 28:1900–1909PubMed Hawley DJ, Wolfe F, Lue FA, Moldofsky H (2001) Seasonal symptom severity in patients with rheumatic diseases: a study of 1424 patients. J Rheumatol 28:1900–1909PubMed
22.
go back to reference Patberg WR, Rasker JJ (2004) Weather effects in rheumatoid arthritis: from controversy to consensus. A review J Rheumatol 31:1327–1334PubMed Patberg WR, Rasker JJ (2004) Weather effects in rheumatoid arthritis: from controversy to consensus. A review J Rheumatol 31:1327–1334PubMed
25.
go back to reference Watson HR, Robb R, Belcher G, Belch JJF (1999) Seasonal variation of Raynaud’s phenomenon secondary to systemic sclerosis. J Rheumatol 26:1734–1737PubMed Watson HR, Robb R, Belcher G, Belch JJF (1999) Seasonal variation of Raynaud’s phenomenon secondary to systemic sclerosis. J Rheumatol 26:1734–1737PubMed
29.
go back to reference Strusberg I, Mendelberg RC, Serra HA, Strusberg AM (2002) Influence of weather conditions on rheumatic pain. J Rheumatol 29:335–338PubMed Strusberg I, Mendelberg RC, Serra HA, Strusberg AM (2002) Influence of weather conditions on rheumatic pain. J Rheumatol 29:335–338PubMed
Metadata
Title
Seasonal residual activity in adult familial Mediterranean fever: a longitudinal observational study
Authors
Sevtap Acer Kasman
Mehmet Tuncay Duruöz
Publication date
08-06-2022
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 9/2022
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-022-05156-7

Other articles of this Issue 9/2022

Rheumatology International 9/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine